Deep Lipidomics in Human Plasma: Cardiometabolic Disease Risk and Effect of Dietary Fat ModulationFabian Eichelmann, Matthias B. Schulze, Laury Sellem et al.|Circulation|2022Cited by 113
Association of the odd-chain fatty acid content in lipid groups with type 2 diabetes risk: A targeted analysis of lipidomics data in the EPIC-Potsdam cohortMarcela Prada, Matthias B. Schulze, Fabian Eichelmann et al.|Clinical Nutrition|2021Cited by 76
Lipidome changes due to improved dietary fat quality inform cardiometabolic risk reduction and precision nutritionFabian Eichelmann, Clemens Wittenbecher, Marcela Prada et al.|Nature Medicine|2024Cited by 62
Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiologyClemens Wittenbecher, Matthias B. Schulze, Rafael R. C. Cuadrat et al.|Nature Communications|2022Cited by 56
Plasma Lipidomic n-6 Polyunsaturated Fatty Acids and Type 2 Diabetes Risk in the EPIC-Potsdam Prospective Cohort StudyMarcela Prada, Matthias B. Schulze, Fabian Eichelmann et al.|Diabetes Care|2023Cited by 28